Understanding Brain Tumours

What is this condition?

A brain tumour is an abnormal growth inside the skull. Some arise from brain tissue, while others arise from the coverings, nerves, pituitary gland or spread from cancer elsewhere in the body. The words benign and malignant describe biology, but even a non-cancerous tumour can be serious when it presses on the brain, blocks cerebrospinal-fluid pathways or affects vision, speech, movement or personality.

What symptoms can it cause?

• New or steadily worsening headache, especially with early-morning vomiting
• A first seizure or a change in a known seizure pattern
• Weakness, numbness, imbalance, speech difficulty or personality change
• Loss of vision, double vision, hearing change or hormonal symptoms

How is it assessed and diagnosed?

Contrast-enhanced MRI is usually the main study. CT is important in emergencies or when bone and bleeding must be assessed. Depending on the suspected tumour, visual-field testing, hearing tests, hormone tests, body imaging or functional MRI/tractography may be added. A final diagnosis often requires tissue examined by a neuropathologist, including molecular tests that now help classify many gliomas.

Treatment without surgery

A small tumour with reassuring imaging and no important symptoms may be observed with planned MRI. Steroids can temporarily reduce swelling; anti-seizure medicine is used when indicated. Radiotherapy, stereotactic radiosurgery, chemotherapy or targeted treatment may be primary or additional treatment depending on tumour type.

When is surgery or a procedure considered?

Surgery is considered to obtain a diagnosis, relieve pressure, treat hydrocephalus, reduce tumour volume, control seizures or protect neurological function. Urgency rises when consciousness falls, weakness progresses, vision is threatened, a large mass causes shift, or fluid pathways are blocked. The goal may be complete removal, safe partial removal or biopsy—whichever best balances benefit and function.

Treatment and procedure options

• Image-guided biopsy through a small opening
• Craniotomy with microsurgical tumour removal
• Awake mapping or functional guidance for tumours near speech or movement networks
• Endoscopic approaches for selected ventricular, pituitary or skull-base lesions
• Radiotherapy, radiosurgery and drug treatment according to pathology

Risks from the disease and from treatment

An untreated tumour may enlarge, cause permanent neurological loss, seizures, hydrocephalus, dangerous intracranial pressure or spread. The risk and speed differ greatly between tumour types; this is why the pathology and serial imaging matter. No procedure is risk-free. General risks include anaesthetic problems, bleeding, infection, blood clots and delayed healing. Neurological risks depend strongly on the exact structure being treated and may include new weakness, numbness, speech or vision change, seizure, cerebrospinal-fluid leakage, need for another procedure or failure to obtain the hoped-for relief. The surgeon should discuss the risks that apply to the individual case.

Recovery and follow-up

Hospital stay and recovery vary from a short biopsy admission to several days after craniotomy. The pathology report determines whether further treatment is needed. Rehabilitation, seizure precautions, steroid tapering and surveillance MRI should be clearly planned before discharge. Recovery is not judged only by the first few days. Pain control, wound care, nutrition, safe mobilisation, physiotherapy and planned follow-up all matter. Some symptoms improve quickly after pressure is relieved; others recover gradually over weeks or months, and permanent nerve injury may not fully reverse.

Preparing for your consultation

Bring the original MRI/CT images or digital files, written reports, previous prescriptions, a current medicine list, and any operative or pathology records. For sudden warning symptoms, use the nearest emergency department rather than waiting for a routine appointment.

Authoritative patient-information sources

• AANS — Classification of Brain Tumors: https://www.aans.org/patients/conditions-treatments/classification-of-brain-tumors/
• US National Cancer Institute — Adult Central Nervous System Tumors: https://www.cancer.gov/types/brain/patient/adult-brain-treatment-pdq